Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine add-on therapy for bipolar depression
IRCT20251011067589N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of acetylcysteine in bipolar disorder (BD) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Depressive symptoms. Started Dec 2025; status: completed.
02
Drugs
acetylcysteine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on IRCT20251011067589N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251011067589N1.